Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Are Insiders Buying Or Selling Pagaya Pgyww Stock Price At 0.04 Down 2.27 20260410 Jakk Stock Analysis Jakks Pacific Inc. Toy Stock Sits At 20.17 With Mild Daily Gain 20260403 1 Is Cna Financial Cna Stock Safe To Buy Now Price At 46.19 Down 0.12 20260406 Will Amer Realty Arl Stock Outperform Peers Arl Q3 2024 Earnings American Realty Investors Inc. Posts 1.08 Eps 20260409 1 Is Seabridge Sa Stock Good For Passive Investors Price At 29.99 Down 0.50 20260406 What TransCode Therapeutics RNAZ flagged as biggest challenges ahead Q4 2024 Below Expectations Why Sanmina Corporation SANM deserves a deeper look right now Modest Gains 20260508 PSAN Public reports quarterly results as preferred dividend coverage remains stable amid rate environment EHang EH Stock Industry Rotation On the Radar 20260418 Select WTTR Stock Wall Street View Market Focus 20260422 PSKY Paramount posts steep Q4 2025 EPS miss and slight revenue dip shares edge higher CFND C1 Fund quarterly results show solid broad client gains management targets accelerated sustainable finance expansion Is Ares Mgmt ARES stock influenced by uncertainty Ares Mgmt Posts 16 EPS Miss Vs Street Estimates ABUS Arbutus posts narrower Q4 2025 loss and 128 percent revenue growth as shares dip 117 percent today Global X Social Media ETF SOCL Featured Among Top 2025 Thematic ETF Picks for CrossSector Alpha Generation How Aspen Aero ASPN responds when competition intensifies Risk Aversion 20260506 FedEx Corporation FDX Institutional Value Strategy Unveils New Position In Global Logistics Leader OXLCG Oxford notes miss Q4 EPS by 74 but investors shrug stock edges up 016 Why Gaia GAIA looks attractive at current levels 234 20260506 Trump Acquires Palantir Shares Before Public Endorsement on Truth Social Ethics Records Reveal Tech Lifts Wall Street Toward Records Amid Broad Market Weakness Following Inflation Concerns MKS MKSI Q1 2026 Beat Revenue NA EPS Exceeds by Significant Iran Conflict Casts Shadow Over TrumpXi Summit Delaying Tariff and Rare Earth Talks NeuroOne NMTC Slips 315 Testing 424 Support 20260515 Royalty RPRX Reports Strong Q1 2026 Revenue NA EPS Beats Nuveen SP500 BXMX Falls 207 Watching 1260 Support 20260514 AI Bidding Wars Intensify Big Tech and Startups Lock Horns Over Elite Talent Huntington HBANZ Rallies 084 as Bulls Target 2155 20260520 Methanex Corporation MEOH Q1 2026 Earnings Miss EPS 030 vs 042 Expected Maze Therapeutics MAZE Q1 2026 Earnings Surprise EPS 045 Up Significant 8x8 Reports Fourth Quarter Fiscal 2026 Earnings Key Insights from Investor Call Goldman Sachs Maintains Bullish Gold Outlook Amid Rising Central Bank Demand Bitcoin Slips Below 76000 as Iran Tensions Rise and ETF Outflows Accelerate Caseys General Stores Identified as Jim Cramers Hidden Gem Michael Price Advocates Contrarian Approach for Navigating Market Volatility High Court Criticizes UOB for Inconsistent Legal Stances on Late Mortgage Payment Fees WYFI Q1 2026 Earnings EPS Misses Estimates Stock Climbs 4 IDCC Q1 2026 Earnings EPS Surges Past Estimates on Strong Licensing Revenue Stock Declines Clearwater Analytics Q1 2026 Earnings EPS Slightly Misses Estimates Stock Slides WORX Q3 2025 Earnings EPS Loss of 015 Amid Significant Stock Surge ADNT Q1 2026 Earnings EPS Surpasses Estimates by 172 on Strong Operational Execution Bone Biologics Corp Warrants BBLGW Holding Steady at 1415 After a Flat Session Algonquin Power Utilities Preferred Shares AQNB Edge Higher Amidst Steady BondLike Trading Rapport Therapeutics RAPP Holds Steady as Minor Decline Tests Key Support Levels MKDWELL Tech Inc MKDW Rises 247 as Shares Test Key Resistance Level Sharps Technology Inc STSS Q3 2025 Earnings Deepening Losses Overshadow No Revenue Quarter Corn Futures Face Pressure From Weakening Crude Oil Prices NVST Q1 2026 Earnings EPS Beats Estimates by Nearly 13 as Stock Slips Riverview Bancorp Inc RVSB Q1 2026 Earnings EPS Misses Estimates Amid Tight Margins XORTX Therapeutics Q1 2024 Earnings Steep EPS Miss Highlights PreRevenue Biotech Hurdles